Eric Schmidt Google would avoid recruiting from. According to a court filing, another email exchange shows Google's human resources director asking Schmidt about sharing its no-cold call agreements with competitors. Schmidt responded that he preferred it be shared "verbally, since I don't want to create a paper trail over which we can be sued later?" On 28 August 2006, Schmidt was elected to Apple Inc.'s board of directors, a position he held until August 2009. Schmidt sat on the boards of trustees of Carnegie Mellon University and Princeton University. He taught at Stanford Graduate School of Business in the 2000s. Schmidt serves
MannKind Corporation in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin). Mann was chief executive officer until January 12, 2015 when Hakan Edstrom became CEO and Mann transitioned to executive chairman. In November 2015, Hakan Edstrom stepped down as CEO and president and will remain until July, 2017 to provide other services for the company. Company founder Alfred Mann stepped in as interim CEO on November 19, 2015. In May 2017, Michael Castagna was named CEO of MannKind Corporation. MannKind's corporate headquarters are in Westlake